临床路径(CP)《学习资料》中联信息产业有限公司地址：重庆市北部新区高新园海王星科技大厦A区5F电话：023-67031919传真：023-67031988网站：www.zlsoft.com目录一、临床路径的背景介绍....................41.产生背景..........................................................................................................................................42.国外临床路径应用状况及评价..............................................................................................43.国内临床路径应用状况及评价..............................................................................................51)临床路径应用范围..............................................................................................................52)实施临床路径的医院级别与隶属关系......................................................................63)实施临床路径病种和路径分析.....................................................................................6二、卫生部临床路径推进路线表..............9三、临床路径相关知识......................121.临床路径的概念.........................................................................................................................122.临床路径的组成内容...............................................................................................................123.临床路径的要素.........................................................................................................................134.临床路径与诊疗指南的比较特点.......................................................................................135.临床路径与传统医疗模式的区别.......................................................................................136.临床路径的优点.........................................................................................................................147.临床路径的意义.........................................................................................................................14四、卫生部临床路径管理指导原则解读.......161.组织管理........................................................................................................................................161)临床路径技术管理委员会：.......................................................................................162)临床路径指导评价小组.................................................................................................163)临床路径实施小组...........................................................................................................172.开发与制定...................................................................................................................................171)病种选择：.........................................................................................................................172)临床路径诊疗项目...........................................................................................................183)确定流程时间.....................................................................................................................184)临床路径文本.....................................................................................................................183.实施.................................................................................................................................................201...
